Industries > Pharma > Global Clinical Nutrition Market Forecast 2019-2029

Global Clinical Nutrition Market Forecast 2019-2029

Infant Nutrition, Enteral Nutrition, Parenteral Nutrition

PUBLISHED: 29 April 2019
PAGES: 144
PRODUCT CODE: PHA0388

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0388 Categories: , Tag:

The global clinical nutrition market is estimated at $41bn in 2016 and is expected to grow at a CAGR of 5.3% from 2017-2027. The infant nutrition segment held the largest market share, with $24.1 billion in value in 2016 and is expected to grow at a CAGR of 4.9% for the period 2017-2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 144-page report you will receive 150 charts – all unavailable elsewhere.

The 144-page report provides clear detailed insight into the global clinical nutrition market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Clinical Nutrition Market forecasts from 2019-2029

This report also shows forecast revenue to 2029 for the leading segments and sub segments of the clinical nutrition market:

Infant Nutrition:
– Milk-based
– Soy-based
– Organic
– Probiotic / prebiotic
– Others

Enteral Nutrition
– Standard
– Enteral Nutrition for Chronic Illnesses

Parenteral Nutrition

Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
– North America: the US and Rest of North America
– Europe: Germany, France, the UK and Rest of Europe
– Asia-Pacific: China, Japan, India and Rest of Asia-Pacific
– Rest of the World (RoW): Middle East and Rest of RoW

Global Clinical Nutrition Market Forecast 2017-2027

Each regional market is further segmented into the leading segments and sub segments of the clinical nutrition market. Whereas, each national market is further segmented into the leading segments of the clinical nutrition market.

• This report discusses the leading companies that hold the majority of market shares in the clinical nutrition market:
– Baxter International
– Abbott Laboratories
– B. Braun Melsungen AG
– Nestle S.A.
– Groupe Danone
– Mead Johnson
– Fresenius Kabi
– Hospira
– Perrigo

• This report also discusses Porter’s Five Forces Analysis. These forces analyze the clinical nutrition market from five different perspectives such as competitive rivalry within the industry; threat of new entrants; bargaining power of suppliers; bargaining power of buyers; and threat of substitute products.

Visiongain’s study is intended for anyone requiring commercial analyses for the clinical nutrition market. You find data, trends and predictions.

Buy our report today Global Clinical Nutrition Market Forecast 2019-2029: Infant Nutrition, Enteral Nutrition, Parenteral Nutrition.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category